|
Covid study
|
10
|
Resverlogix Corp.
|
Feb 12, 2024 01:14PM
|
|
New Phase 2 Trial
|
8
|
Zenith Epigenetics
|
Jan 03, 2023 02:03PM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
8
|
Resverlogix Corp.
|
Aug 29, 2023 11:13AM
|
|
Re: Narmac
|
8
|
Resverlogix Corp.
|
Aug 09, 2024 12:37PM
|
|
New Phase 1 NCI trial
|
7
|
Zenith Epigenetics
|
May 24, 2023 05:43PM
|
|
Re: why on earth
|
7
|
Resverlogix Corp.
|
May 13, 2024 04:26PM
|
|
Re: Link to 2023 AGM presentation is up
|
7
|
Resverlogix Corp.
|
Jun 21, 2023 02:07PM
|
|
Re: Recent publications:
|
6
|
Resverlogix Corp.
|
Sep 27, 2023 02:25PM
|
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
6
|
Zenith Epigenetics
|
Oct 29, 2023 09:37PM
|
|
Re: IR - "but all I can tell you at the moment is that we believe we are making real progress towards achieving our goals."
|
6
|
Resverlogix Corp.
|
May 11, 2023 03:17PM
|
|
Re: Toxicity
|
6
|
Zenith Epigenetics
|
Nov 03, 2022 03:28PM
|
|
Re: Latest on COVID-19
|
6
|
Resverlogix Corp.
|
Sep 28, 2022 12:04PM
|
|
Re: Long Covid
|
6
|
Resverlogix Corp.
|
Jan 22, 2024 02:21PM
|
|
Toxicity
|
5
|
Zenith Epigenetics
|
Nov 02, 2022 03:10PM
|
|
Re: Sent this to IR
|
5
|
Resverlogix Corp.
|
Nov 16, 2023 04:52PM
|
|
Re: Lu stepping down
|
5
|
Resverlogix Corp.
|
Feb 22, 2024 06:12PM
|
|
Re: Some history
|
5
|
Resverlogix Corp.
|
Jan 25, 2023 01:01PM
|
|
Re: Bad idea?
|
5
|
Resverlogix Corp.
|
Dec 18, 2023 04:08PM
|
|
Re: Additional Reports Of Exempt Distribution.
|
5
|
Zenith Epigenetics
|
Jun 06, 2024 11:25AM
|
|
Re: 2 year extension
|
5
|
Resverlogix Corp.
|
May 13, 2024 05:11PM
|
